WH: GlaxoSmithKline's Monoclonal Antibody Treatment Is the Only One Effective Against Omicron Variant

The White House COVID-19 response team announced Wednesday that it has ordered more than 1 million treatment courses of GlaxoSmithKline’s monoclonal antibody treatment after discovering that two out of the three monoclonal antibody treatments are ineffective against the Omicron variant.

Related Keywords

Washington ,United States ,White House ,District Of Columbia ,Jeff Zients ,Johnson Janssen Covid ,Pfizer ,Glaxosmithkline ,Astrazeneca ,Johnson Janssen ,Getty Images ,For Merck ,